Search research articles
Contact Us
Filters
Showing results (451-460 of 670) with videos related to
Page
of 67
Sort By:
Journal of Psychopharmacology (Oxford, England)
|
June 12, 2016
Oral administration of D-alanine in monkeys robustly increases plasma and cerebrospinal fluid levels but experimental D-amino acid oxidase inhibitors had minimal effect
Camilo Rojas, Jesse Alt, Nancy A Ator, et al.
Molecular Pharmaceutics
|
September 11, 2019
Enhanced Oral Bioavailability of 2-(Phosphonomethyl)-pentanedioic Acid (2-PMPA) from its (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl (ODOL)-Based Prodrugs
Ranjeet P Dash, Tomáš Tichý, Vijayabhaskar Veeravalli, et al.
Molecular Endocrinology (Baltimore, Md.)
|
May 10, 2012
FOXO1 mediates the autocrine effect of endothelin-1 on endothelial cell survival
Vincenza Cifarelli, Sojin Lee, Dae Hyun Kim, et al.
Journal of Neurochemistry
|
September 30, 2005
Mice lacking glutamate carboxypeptidase II are protected from peripheral neuropathy and ischemic brain injury
Dean J Bacich, Krystyna M Wozniak, X-C May Lu, et al.
The American Journal of Tropical Medicine and Hygiene
|
July 27, 2022
A Low-Resource Oxygen Blender Prototype for Use in Modified Bubble CPAP Circuits: Results from Design Feasibility Workshops
Andrew G Wu, Sreyleak Luch, Jared R Floersch, et al.
Brain, Behavior, & Immunity - Health
|
June 23, 2022
Glutamine antagonist JHU083 improves psychosocial behavior and sleep deficits in EcoHIV-infected mice
Benjamin J Bell, Kristen R Hollinger, Pragney Deme, et al.
Biochemical Pharmacology
|
December 1, 2009
Poly(ADP-ribose) polymerase (PARP) inhibition counteracts multiple manifestations of kidney disease in long-term streptozotocin-diabetic rat model
Hanna Shevalye, Roman Stavniichuk, Weizheng Xu, et al.
European Journal of Medicinal Chemistry
|
July 13, 2005
Structure-activity relationship of trihexyphenidyl analogs with respect to the dopamine transporter in the on going search for a cocaine inhibitor
D E Dar, M Thiruvazhi, P Abraham, et al.
Endocrinology
|
April 2, 2010
New therapeutic and biomarker discovery for peripheral diabetic neuropathy: PARP inhibitor, nitrotyrosine, and tumor necrosis factor-{alpha}
Viktor R Drel, Sergey Lupachyk, Hanna Shevalye, et al.
Drug Discovery Today
|
April 2, 2021
Nipping disease in the bud: nSMase2 inhibitors as therapeutics in extracellular vesicle-mediated diseases
Carolyn Tallon, Kristen R Hollinger, Arindom Pal, et al.
Page
of 67
Search research articles
Search
Showing results (451-460 of 670) with videos related to
Sort By:
Page
of 67
Journal of Psychopharmacology (Oxford, England)
|
June 12, 2016
Oral administration of D-alanine in monkeys robustly increases plasma and cerebrospinal fluid levels but experimental D-amino acid oxidase inhibitors had minimal effect
Camilo Rojas, Jesse Alt, Nancy A Ator, et al.
Molecular Pharmaceutics
|
September 11, 2019
Enhanced Oral Bioavailability of 2-(Phosphonomethyl)-pentanedioic Acid (2-PMPA) from its (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl (ODOL)-Based Prodrugs
Ranjeet P Dash, Tomáš Tichý, Vijayabhaskar Veeravalli, et al.
Molecular Endocrinology (Baltimore, Md.)
|
May 10, 2012
FOXO1 mediates the autocrine effect of endothelin-1 on endothelial cell survival
Vincenza Cifarelli, Sojin Lee, Dae Hyun Kim, et al.
Journal of Neurochemistry
|
September 30, 2005
Mice lacking glutamate carboxypeptidase II are protected from peripheral neuropathy and ischemic brain injury
Dean J Bacich, Krystyna M Wozniak, X-C May Lu, et al.
The American Journal of Tropical Medicine and Hygiene
|
July 27, 2022
A Low-Resource Oxygen Blender Prototype for Use in Modified Bubble CPAP Circuits: Results from Design Feasibility Workshops
Andrew G Wu, Sreyleak Luch, Jared R Floersch, et al.
Brain, Behavior, & Immunity - Health
|
June 23, 2022
Glutamine antagonist JHU083 improves psychosocial behavior and sleep deficits in EcoHIV-infected mice
Benjamin J Bell, Kristen R Hollinger, Pragney Deme, et al.
Biochemical Pharmacology
|
December 1, 2009
Poly(ADP-ribose) polymerase (PARP) inhibition counteracts multiple manifestations of kidney disease in long-term streptozotocin-diabetic rat model
Hanna Shevalye, Roman Stavniichuk, Weizheng Xu, et al.
European Journal of Medicinal Chemistry
|
July 13, 2005
Structure-activity relationship of trihexyphenidyl analogs with respect to the dopamine transporter in the on going search for a cocaine inhibitor
D E Dar, M Thiruvazhi, P Abraham, et al.
Endocrinology
|
April 2, 2010
New therapeutic and biomarker discovery for peripheral diabetic neuropathy: PARP inhibitor, nitrotyrosine, and tumor necrosis factor-{alpha}
Viktor R Drel, Sergey Lupachyk, Hanna Shevalye, et al.
Drug Discovery Today
|
April 2, 2021
Nipping disease in the bud: nSMase2 inhibitors as therapeutics in extracellular vesicle-mediated diseases
Carolyn Tallon, Kristen R Hollinger, Arindom Pal, et al.
Page
of 67